Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,239 | 6,275 | 7,640 | 9,598 | 4,752 |
| Receivables | 136 | 201 | 193 | 209 | 218 |
| TOTAL | $5,375 | $6,476 | $7,833 | $9,807 | $4,970 |
| Non-Current Assets | |||||
| PPE Net | 373 | 396 | 413 | 431 | 412 |
| Other Non-Current Assets | 421 | 456 | 489 | 538 | 125 |
| TOTAL | $794 | $852 | $902 | $969 | $537 |
| Total Assets | $6,169 | $7,328 | $8,735 | $10,776 | $5,507 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 937 | 874 | 1,173 | 1,658 | 1,307 |
| TOTAL | $1,052 | $997 | $1,304 | $1,793 | $1,307 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 824 | 1,027 | 1,287 | 2,929 | 485 |
| TOTAL | $824 | $1,027 | $1,287 | $2,929 | $485 |
| Total Liabilities | $1,876 | $2,024 | $2,591 | $4,722 | $1,792 |
| Shareholders' Equity | |||||
| Retained earnings | -29,185 | -27,222 | -25,231 | -24,548 | -22,427 |
| Other shareholders' equity | 5,055 | 4,422 | 4,004 | 3,792 | 3,772 |
| TOTAL | $4,293 | $5,304 | $6,144 | $6,054 | $3,715 |
| Total Liabilities And Equity | $6,169 | $7,328 | $8,735 | $10,776 | $5,507 |